Literature DB >> 7390030

Dissociated visual development: electrodiagnostic studies in infants who are 'slow to see'.

D H Mellor, A R Fielder.   

Abstract

Four infants were studied who failed to show any visual interest or following responses in the first three months of life. Although no definite ocular abnormalities were found at the time of presentation, both the parents and their medical advisers initially had serious concerns about the infants' visual prognosis. Initial electroretinograms (ERG) were found to be unequivocally normal, but three of the infants showed absent or impaired cortical visual evoked responses (VER). The fourth infant had an initial VER which was immature. Subsequently, all the infants showed increasing visual responsiveness from three to four months of age and all now have visual behaviour and general development appropriate to their ages. The VERs were repeated after four months of age and all showed normal responses. It is concluded that poor or even absent VER responses in early infancy may not always indicate a poor prognosis for vision. The possible mechanisms of this visual maturational lag are discussed.

Entities:  

Mesh:

Year:  1980        PMID: 7390030     DOI: 10.1111/j.1469-8749.1980.tb03712.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  Delayed visual maturation in infancy.

Authors:  C S Hoyt; G Jastrzebski; E Marg
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

2.  Delayed visual maturation.

Authors:  S Harel; M Holtzman; M Feinsod
Journal:  Arch Dis Child       Date:  1983-04       Impact factor: 3.791

3.  Sporadic aniridia and Wilms' tumor: visual function evaluation of three cases.

Authors:  C Harnois; H M Boisjoly; V Jotterand
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

4.  Delayed visual maturation.

Authors:  G F Cole; J Hungerford; R B Jones
Journal:  Arch Dis Child       Date:  1984-02       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.